Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions....
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DEYNET-VUCENOVIC ANNETTE GRASSMANN OLAF PINARD EMMANUEL SCHWITTER URS LINDENSTRUTH KAI DIODONE RALPH BUBENDORF ANDRE ROHRER FRANZISKA E |
| description | The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8039473B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8039473B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8039473B23</originalsourceid><addsrcrecordid>eNqNjMEKwjAMhnfxIOo79LiBAe021KuieJ-ehozhUlbomtJt4HwRX9eIA68SSPKHL980eGVkdCUU-aYVpESeQBiDMj15ghQ6r797g109GHCD15W2IGEwETjt0JdPzmvOkKfwwUqLbW8UWT5JCMMsArnk-skYH33c6TGwqUbGb-M_WZwHE1WaFhfjnAXidLwczoCOCmxdeUeLXXHNtqt4l2zivYz_QN5U5E6s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone</title><source>esp@cenet</source><creator>DEYNET-VUCENOVIC ANNETTE ; GRASSMANN OLAF ; PINARD EMMANUEL ; SCHWITTER URS ; LINDENSTRUTH KAI ; DIODONE RALPH ; BUBENDORF ANDRE ; ROHRER FRANZISKA E</creator><creatorcontrib>DEYNET-VUCENOVIC ANNETTE ; GRASSMANN OLAF ; PINARD EMMANUEL ; SCHWITTER URS ; LINDENSTRUTH KAI ; DIODONE RALPH ; BUBENDORF ANDRE ; ROHRER FRANZISKA E</creatorcontrib><description>The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111018&DB=EPODOC&CC=US&NR=8039473B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111018&DB=EPODOC&CC=US&NR=8039473B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEYNET-VUCENOVIC ANNETTE</creatorcontrib><creatorcontrib>GRASSMANN OLAF</creatorcontrib><creatorcontrib>PINARD EMMANUEL</creatorcontrib><creatorcontrib>SCHWITTER URS</creatorcontrib><creatorcontrib>LINDENSTRUTH KAI</creatorcontrib><creatorcontrib>DIODONE RALPH</creatorcontrib><creatorcontrib>BUBENDORF ANDRE</creatorcontrib><creatorcontrib>ROHRER FRANZISKA E</creatorcontrib><title>Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone</title><description>The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKwjAMhnfxIOo79LiBAe021KuieJ-ehozhUlbomtJt4HwRX9eIA68SSPKHL980eGVkdCUU-aYVpESeQBiDMj15ghQ6r797g109GHCD15W2IGEwETjt0JdPzmvOkKfwwUqLbW8UWT5JCMMsArnk-skYH33c6TGwqUbGb-M_WZwHE1WaFhfjnAXidLwczoCOCmxdeUeLXXHNtqt4l2zivYz_QN5U5E6s</recordid><startdate>20111018</startdate><enddate>20111018</enddate><creator>DEYNET-VUCENOVIC ANNETTE</creator><creator>GRASSMANN OLAF</creator><creator>PINARD EMMANUEL</creator><creator>SCHWITTER URS</creator><creator>LINDENSTRUTH KAI</creator><creator>DIODONE RALPH</creator><creator>BUBENDORF ANDRE</creator><creator>ROHRER FRANZISKA E</creator><scope>EVB</scope></search><sort><creationdate>20111018</creationdate><title>Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone</title><author>DEYNET-VUCENOVIC ANNETTE ; GRASSMANN OLAF ; PINARD EMMANUEL ; SCHWITTER URS ; LINDENSTRUTH KAI ; DIODONE RALPH ; BUBENDORF ANDRE ; ROHRER FRANZISKA E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8039473B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DEYNET-VUCENOVIC ANNETTE</creatorcontrib><creatorcontrib>GRASSMANN OLAF</creatorcontrib><creatorcontrib>PINARD EMMANUEL</creatorcontrib><creatorcontrib>SCHWITTER URS</creatorcontrib><creatorcontrib>LINDENSTRUTH KAI</creatorcontrib><creatorcontrib>DIODONE RALPH</creatorcontrib><creatorcontrib>BUBENDORF ANDRE</creatorcontrib><creatorcontrib>ROHRER FRANZISKA E</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEYNET-VUCENOVIC ANNETTE</au><au>GRASSMANN OLAF</au><au>PINARD EMMANUEL</au><au>SCHWITTER URS</au><au>LINDENSTRUTH KAI</au><au>DIODONE RALPH</au><au>BUBENDORF ANDRE</au><au>ROHRER FRANZISKA E</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone</title><date>2011-10-18</date><risdate>2011</risdate><abstract>The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8039473B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEYNET-VUCENOVIC%20ANNETTE&rft.date=2011-10-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8039473B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |